Angiotensin-Converting Enzyme-2 (ACE-2) with Interferon-Induced Transmembrane Protein-3 (IFITM-3) Genetic Variants and Interleukin-6 as Severity and Risk Predictors among COVID-19 Egyptian Population

Table 6

Comparison between IL-6 levels before and after receiving anti-IL-6 treatment regarding group severity (n = 46).

Cases	(n = 46)	IL-6 level (pg\ml)
		1^st reading		Follow-up reading
		Mean ± SD.	Median (min.–max.)	Mean ± SD.	Median (min.–max.)
Mild/moderate	11	48.77 ± 66.20	18.0 (8.65–224.0)	21.88 ± 33.18	8.0 (6.50–117.0)	0.003
Severe	12	60.25 ± 85.89	18.50 (5.0–237.0)	208.4 ± 257.4	79.0 (27.0–726.0)	0.002
Critical	23	146.0 ± 132.5	115.0 (16.30–531.0)	249.3 ± 151.4	243.0 (9.0–633.0)	<0.001

SD: standard deviation. : value for relation between 1^st reading and follow-up reading. Statistically significant at .